{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T16:49:03Z","timestamp":1773247743863,"version":"3.50.1"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,10,9]],"date-time":"2020-10-09T00:00:00Z","timestamp":1602201600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,10,9]],"date-time":"2020-10-09T00:00:00Z","timestamp":1602201600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diagn Pathol"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Epstein\u2013Barr virus (EBV) is associated with the pathogenesis of a variety of malignancies, most notably lymphomas. Especially in the background of immunodeficiency, such as primary immunodeficiency disorder (PID) and post-transplant lymphoproliferative disorder (PTLD), the role of EBV might be crucial. PIDs are rare heterogeneous diseases affecting the development and\/or the function of the innate and adaptive immune system. Malignancy is the second-highest cause of death after infection, and lymphoma accounts for about half of malignancies. The most frequently reported lymphoma type is diffuse large B-cell lymphoma (DLBCL) and the incidence of T-cell lymphoma is rare. PTLDs are also rare serious lymphoid and\/or plasmacytic proliferative disorders that occur after undergoing solid organ or hematopoietic stem cell transplantation (HSCT). In the context of HSCT, most reported PTLDs have occurred in patients who received allogenic HSCT, but only a few cases have been reported in autologous HSCT (AutoHSCT) recipients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Case presentation<\/jats:title>\n                    <jats:p>A 53-year-old female patient initially presented with enlargement of the left cervical lymph nodes and was diagnosed with EBV-positive DLBCL. She was treated with R-CHOP, R-ACES, and AutoHSCT and went into remission. Four years later, computed tomography results revealed multiple lung nodules and abnormal infiltration, and sustained and progressing hypogammaglobulinemia was observed. The pathological specimen of video-assisted thoracoscopic surgical lung biopsy demonstrated extensive invasion of lymphocytes with notable granuloma findings. Flow cytometric immunophenotyping analysis showed that lymphocytes were positive for CD3 and CD5; especially, CD3 was expressed in the cytoplasm. Southern blot analysis revealed rearrangements of the T-cell receptor C\u03b21 gene. She was diagnosed with peripheral T-cell lymphoma, not otherwise specified, accompanied by notable granulomatous lesions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Here, as a unique case of metachronous B-cell and T-cell lymphoma, we report a rare case of T-cell lymphoma that mainly affected the lungs with the presentation of notable granulomatous findings following AutoHSCT for EBV-positive DLBCL at the age of 53\u2009years. These lung lesions of granulomatous T-cell lymphoma could be related to the underlying primary immunodeficiency background associated with sustained hypogammaglobulinemia.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13000-020-01038-3","type":"journal-article","created":{"date-parts":[[2020,10,9]],"date-time":"2020-10-09T11:02:54Z","timestamp":1602241374000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["T-cell lymphoma with a granulomatous lesion of the lungs after autologous hematopoietic stem cell transplantation for Epstein\u2013Barr virus-positive diffuse large B-cell lymphoma: a unique rare case of metachronous B-cell and T-cell lymphoma"],"prefix":"10.1186","volume":"15","author":[{"given":"Yusuke","family":"Kajimoto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuhiro","family":"Terasaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mika","family":"Terasaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinobu","family":"Kunugi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yugo","family":"Okabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Wakita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koiti","family":"Inokuchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akira","family":"Shimizu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,10,9]]},"reference":[{"key":"1038_CR1","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.pathol.2019.09.006","volume":"52","author":"ML Marques-Piubelli","year":"2020","unstructured":"Marques-Piubelli ML, Salas YI, Pachas C, Becker-Hecker R, Vega F, Miranda RN. Epstein-Barr virus-associated B-cell lymphoproliferative disorders and lymphomas: a review. Pathology. 2020;52:40\u201352.","journal-title":"Pathology"},{"key":"1038_CR2","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1007\/s10875-017-0464-9","volume":"38","author":"C Picard","year":"2018","unstructured":"Picard C, Bobby Gaspar H, Al-Herz W, Bousfiha A, Casanova JL, Chatila T, et al. International Union of Immunological Societies: 2017 primary immunodeficiency diseases committee report on inborn errors of immunity. J Clin Immunol. 2018;38:96\u2013128.","journal-title":"J Clin Immunol"},{"key":"1038_CR3","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1007\/s10875-014-0102-8","volume":"34","author":"L Kobrynski","year":"2014","unstructured":"Kobrynski L, Powell RW, Bowen S. Prevalence and morbidity of primary immunodeficiency diseases, United States 2001-2007. J Clin Immunol. 2014;34:954\u201361.","journal-title":"J Clin Immunol"},{"key":"1038_CR4","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1002\/ajh.21903","volume":"86","author":"RS Shapiro","year":"2011","unstructured":"Shapiro RS. Malignancies in the setting of primary immunodeficiency: implications for hematologists\/oncologists. Am J Hematol. 2011;86:48\u201355.","journal-title":"Am J Hematol"},{"key":"1038_CR5","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1016\/j.jaci.2017.05.024","volume":"141","author":"PC Mayor","year":"2018","unstructured":"Mayor PC, Eng KH, Singel KL, Abrams SI, Odunsi K, Moysich KB, et al. Cancer in primary immunodeficiency diseases: Cancer incidence in the United States immune deficiency network registry. J Allergy Clin Immunol. 2018;141:1028\u201335.","journal-title":"J Allergy Clin Immunol"},{"key":"1038_CR6","doi-asserted-by":"publisher","first-page":"777","DOI":"10.3389\/fimmu.2019.00777","volume":"10","author":"IB Riaz","year":"2019","unstructured":"Riaz IB, Faridi W, Patnaik MM, Abraham RS. A systematic review on predisposition to lymphoid (B and T cell) neoplasias in patients with primary immunodeficiencies and immune dysregulatory disorders (inborn errors of immunity). Front Immunol. 2019;10:777.","journal-title":"Front Immunol"},{"key":"1038_CR7","first-page":"31","volume":"86","author":"RA Hermaszewski","year":"1993","unstructured":"Hermaszewski RA, Webster AD. Primary hypogammaglobulinaemia: a survey of clinical manifestations and complications. Q J Med. 1993;86:31\u201342.","journal-title":"Q J Med"},{"key":"1038_CR8","first-page":"453","volume-title":"WHO classification of tumors of haematopoietic and lymphoid tissues","author":"SH Swerdlow","year":"2017","unstructured":"Swerdlow SH, Webber SA, Chadburn A, Ferry JA. Post-transplant lymphoproliferative disorders. In: Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, J\u00fcrgen T, editors. WHO classification of tumors of haematopoietic and lymphoid tissues. Lyon: International Agency for Research on Cancer (IARC); 2017. p. 453\u201362."},{"key":"1038_CR9","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1034\/j.1399-3062.2001.003002070.x","volume":"3","author":"SM Cockfield","year":"2001","unstructured":"Cockfield SM. Identifying the patient at risk for post-transplant lymphoproliferative disorder. Transpl Infect Dis. 2001;3:70\u20138.","journal-title":"Transpl Infect Dis"},{"key":"1038_CR10","doi-asserted-by":"publisher","first-page":"2190","DOI":"10.3109\/10428194.2013.775436","volume":"54","author":"A Herreman","year":"2013","unstructured":"Herreman A, Dierickx D, Morscio J, Camps J, Bittoun E, Verhoef G, et al. Clinicopathological characteristics of posttransplant lymphoproliferative disorders of T-cell origin: single-center series of nine cases and meta-analysis of 147 reported cases. Leuk Lymphoma. 2013;54:2190\u20139.","journal-title":"Leuk Lymphoma"},{"key":"1038_CR11","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1309\/LYXN3RGF7D7KPYG0","volume":"127","author":"SH Swerdlow","year":"2007","unstructured":"Swerdlow SH. T-cell and NK-cell posttransplantation lymphoproliferative disorders. Am J Clin Pathol. 2007;127:887\u201395.","journal-title":"Am J Clin Pathol"},{"key":"1038_CR12","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1038\/sj.bmt.1702721","volume":"26","author":"Y Yufu","year":"2000","unstructured":"Yufu Y, Kimura M, Kawano R, Noguchi Y, Takatsuki H, Uike N, et al. Epstein-Barr virus-associated T cell lymphoproliferative disorder following autologous blood stem cell transplantation for relapsed Hodgkin's disease. Bone Marrow Transplant. 2000;26:1339\u201341.","journal-title":"Bone Marrow Transplant"},{"key":"1038_CR13","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1038\/sj.bmt.1704298","volume":"33","author":"H Narumi","year":"2004","unstructured":"Narumi H, Kojima K, Matsuo Y, Shikata H, Sekiya K, Niiya T, et al. T-cell large granular lymphocytic leukemia occurring after autologous peripheral blood stem cell transplantation. Bone Marrow Transplant. 2004;33:99\u2013101.","journal-title":"Bone Marrow Transplant"},{"key":"1038_CR14","first-page":"1065","volume":"46","author":"K Miyazaki","year":"2005","unstructured":"Miyazaki K, Masuya M, Yamaguchi M, Isaka S, Nakase K, Kobayashi T, et al. Angioimmunoblastic T-cell lymphoma occurring four months after autologous peripheral blood stem cell transplantation with high-dose chemotherapy for follicular lymphoma. Rinsho Ketsueki. 2005;46:1065\u201370.","journal-title":"Rinsho Ketsueki"},{"key":"1038_CR15","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1016\/j.leukres.2005.10.022","volume":"30","author":"N Awaya","year":"2006","unstructured":"Awaya N, Adachi A, Mori T, Kamata H, Nakahara J, Yokoyama K, et al. Fulminant Epstein-Barr virus (EBV)-associated T-cell lymphoproliferative disorder with hemophagocytosis following autologous peripheral blood stem cell transplantation for relapsed angioimmunoblastic T-cell lymphoma. Leuk Res. 2006;30:1059\u201362.","journal-title":"Leuk Res"},{"key":"1038_CR16","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1097\/01.pas.0000213391.49698.57","volume":"31","author":"VE Nava","year":"2007","unstructured":"Nava VE, Cohen P, Bishop M, Fowler D, Jaffe ES, Ozdemirli M. Enteropathy-type T-cell lymphoma after intestinal diffuse large B-cell lymphoma. Am J Surg Pathol. 2007;31:476\u201380.","journal-title":"Am J Surg Pathol"},{"key":"1038_CR17","first-page":"36","volume":"57","author":"T Ishikawa","year":"2016","unstructured":"Ishikawa T, Shimizu H, Takei T, Koya H, Iriuchishima H, Hosiho T, et al. Monomorphic post-transplant T-lymphoproliferative disorder after autologous stem cell transplantation for multiple myeloma. Rinsho Ketsueki. 2016;57:36\u201340.","journal-title":"Rinsho Ketsueki"},{"key":"1038_CR18","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.2169\/naika.105.1275","volume":"105","author":"R Sumitani","year":"2016","unstructured":"Sumitani R, Sekimoto E, Shibata H, Mori K, Shigekiyo T, Yano M, et al. A case of diffuse large B-cell lymphoma presented Epstein-Barr Virus associated T-cell and B-cell lymphoproliferative disorders followed by autologous peripheral blood stem cell transplantation. Nihon Naika Gakkai Zasshi. 2016;105:1275\u201381.","journal-title":"Nihon Naika Gakkai Zasshi"},{"key":"1038_CR19","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1038\/sj.bmt.1701335","volume":"22","author":"AJ Peniket","year":"1998","unstructured":"Peniket AJ, Perry AR, Williams CD, MacMillan A, Watts MJ, Isaacson PG, et al. A case of EBV-associated lymphoproliferative disease following high-dose therapy and CD34-purified autologous peripheral blood progenitor cell transplantation. Bone Marrow Transplant. 1998;22:307\u20139.","journal-title":"Bone Marrow Transplant"},{"key":"1038_CR20","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1038\/sj.bmt.1701513","volume":"23","author":"A Fassas","year":"1999","unstructured":"Fassas A, Jagannath S, Desikan KR, Shah HR, Shaver R, Waldron J, et al. Lymphomatoid granulomatosis following autologous stem cell transplantation. Bone Marrow Transplant. 1999;23:79\u201381.","journal-title":"Bone Marrow Transplant"},{"key":"1038_CR21","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1038\/sj.bmt.1703603","volume":"30","author":"D Jenkins","year":"2002","unstructured":"Jenkins D, DiFrancesco L, Chaudhry A, Morris D, Gl\u00fcck S, Jones A, et al. Successful treatment of post-transplant lymphoproliferative disorder in autologous blood stem cell transplant recipients. Bone Marrow Transplant. 2002;30:321\u20136.","journal-title":"Bone Marrow Transplant"},{"key":"1038_CR22","first-page":"242","volume":"17","author":"S Takahashi","year":"2007","unstructured":"Takahashi S, Watanabe D, Miura K, Ozawa H, Tamada Y, Hara K, et al. Epstein-Barr virus-associated post-transplant lymphoproliferative disorder presenting with skin involvement after CD34-selected autologous peripheral blood stem cell transplantation. Eur J Dermatol. 2007;17:242\u20134.","journal-title":"Eur J Dermatol"},{"key":"1038_CR23","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1186\/1471-2407-5-109","volume":"5","author":"A Zambelli","year":"2005","unstructured":"Zambelli A, Lilleri D, Baldanti F, Scelsi M, Villani L, Da Prada GA. Hodgkin's disease as unusual presentation of post-transplant lymphoproliferative disorder after autologous hematopoietic cell transplantation for malignant glioma. BMC Cancer. 2005;5:109.","journal-title":"BMC Cancer"},{"key":"1038_CR24","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.3892\/ol.2012.670","volume":"3","author":"S Izumiya","year":"2012","unstructured":"Izumiya S, Ishida M, Hodohara K, Yoshida T, Okabe H. Epstein-Barr virus-associated lymphoproliferative disorder developed following autologous peripheral blood stem cell transplantation for relapsing Hodgkin's lymphoma. Oncol Lett. 2012;3:1203\u20136.","journal-title":"Oncol Lett"},{"key":"1038_CR25","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1016\/j.pathol.2019.05.008","volume":"51","author":"ML Oon","year":"2019","unstructured":"Oon ML, Soon G, Poon LM, Wang S. Development of monomorphic B-cell plasmacytoma post-transplant lymphoproliferative disorder in a patient with previous autologous stem cell transplant. Pathology. 2019;51:644\u20136.","journal-title":"Pathology"},{"key":"1038_CR26","doi-asserted-by":"publisher","first-page":"1604","DOI":"10.1007\/s12032-010-9635-8","volume":"28","author":"GM Viola","year":"2011","unstructured":"Viola GM, Zu Y, Baker KR, Aslam S. Epstein-Barr virus-related lymphoproliferative disorder induced by equine anti-thymocyte globulin therapy. Med Oncol. 2011;28:1604\u20138.","journal-title":"Med Oncol"},{"key":"1038_CR27","doi-asserted-by":"publisher","first-page":"170","DOI":"10.3960\/jslrt.56.170","volume":"56","author":"T Matsuo","year":"2017","unstructured":"Matsuo T, Tanaka T, Fujii N. Orbital MALT lymphoma after autologous stem cell transplantation for follicular lymphoma as relapse of diffuse large B-cell lymphoma. J Clin Exp Hematop. 2017;56:170\u20135.","journal-title":"J Clin Exp Hematop"},{"key":"1038_CR28","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1038\/sj.bmt.1701258","volume":"21","author":"RJ Hauke","year":"1998","unstructured":"Hauke RJ, Greiner TC, Smir BN, Vose JM, Tarantolo SR, Bashir RM, et al. Epstein-Barr virus-associated lymphoproliferative disorder after autologous bone marrow transplantation: report of two cases. Bone Marrow Transplant. 1998;21:1271\u20134.","journal-title":"Bone Marrow Transplant"},{"key":"1038_CR29","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1056\/NEJM198910193211604","volume":"321","author":"L Young","year":"1989","unstructured":"Young L, Alfieri C, Hennessy K, Evans H, O'Hara C, Anderson KC, et al. Expression of Epstein-Barr virus transformation-associated genes in tissues of patients with EBV lymphoproliferative disease. N Engl J Med. 1989;321:1080\u20135.","journal-title":"N Engl J Med"},{"key":"1038_CR30","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1097\/00007890-199306000-00040","volume":"55","author":"NJ Chao","year":"1993","unstructured":"Chao NJ, Berry GJ, Advani R, Horning SJ, Weiss LM, Blume KG. Epstein-Barr virus-associated lymphoproliferative disorder following autologous bone marrow transplantation for non-Hodgkin's lymphoma. Transplantation. 1993;55:1425\u20138.","journal-title":"Transplantation"},{"key":"1038_CR31","first-page":"639","volume":"15","author":"JD Shepherd","year":"1995","unstructured":"Shepherd JD, Gascoyne RD, Barnett MJ, Coghlan JD, Phillips GL. Polyclonal Epstein-Barr virus-associated lymphoproliferative disorder following autografting for chronic myeloid leukemia. Bone Marrow Transplant. 1995;15:639\u201341.","journal-title":"Bone Marrow Transplant"},{"key":"1038_CR32","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1046\/j.1365-2141.1997.2153034.x","volume":"98","author":"M Briz","year":"1997","unstructured":"Briz M, For\u00e9s R, Regidor C, Busto MJ, Ramon y Cajal S, Cabrera R, et al. Epstein-Barr virus associated B-cell lymphoma after autologous bone marrow transplantation for T-cell acute lymphoblastic leukaemia. Br J Haematol. 1997;98:485\u20137.","journal-title":"Br J Haematol"},{"key":"1038_CR33","doi-asserted-by":"publisher","first-page":"20160271","DOI":"10.1098\/rstb.2016.0271","volume":"372","author":"C Shannon-Lowe","year":"2017","unstructured":"Shannon-Lowe C, Rickinson AB, Bell AI. Epstein-Barr virus-associated lymphomas. Philos Trans R Soc Lond Ser B Biol Sci. 2017;372:20160271.","journal-title":"Philos Trans R Soc Lond Ser B Biol Sci"},{"key":"1038_CR34","unstructured":"Nakamura S, Jaffe ES, Swerdlow SH. EBV-positive diffuse large B-cell lymphoma, not otherwise specified (NOS). In: Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, J\u00fcrgen T, editors. WHO classification of tumors of haematopoietic and lymphoid tissues: International Agency for Research on Cancer (IARC); 2017. p. 304\u20136."},{"key":"1038_CR35","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1080\/10428194.2019.1672056","volume":"61","author":"M Herber","year":"2020","unstructured":"Herber M, Mertz P, Dieudonn\u00e9 Y, Guffroy B, Jung S, Gies V, et al. Primary immunodeficiencies and lymphoma: a systematic review of literature. Leuk Lymphoma. 2020;61:274\u201384.","journal-title":"Leuk Lymphoma"},{"key":"1038_CR36","doi-asserted-by":"publisher","first-page":"365","DOI":"10.3389\/fimmu.2016.00365","volume":"7","author":"E Mortaz","year":"2016","unstructured":"Mortaz E, Tabarsi P, Mansouri D, Khosravi A, Garssen J, Velayati A, et al. Cancers related to immunodeficiencies: update and perspectives. Front Immunol. 2016;7:365.","journal-title":"Front Immunol"},{"key":"1038_CR37","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.jaip.2015.07.025","volume":"4","author":"FA Bonilla","year":"2016","unstructured":"Bonilla FA, Barlan I, Chapel H, Costa-Carvalho BT, Cunningham-Rundles C, de la Morena MT, et al. International consensus document (ICON): common variable immunodeficiency disorders. J Allergy Clin Immunol Pract. 2016;4:38\u201359.","journal-title":"J Allergy Clin Immunol Pract"},{"key":"1038_CR38","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/B978-0-12-385991-4.00002-7","volume":"111","author":"PF Yong","year":"2011","unstructured":"Yong PF, Thaventhiran JE, Grimbacher B. \"A rose is a rose is a rose,\" but CVID is not CVID common variable immune deficiency (CVID), what do we know in 2011? Adv Immunol. 2011;111:47\u2013107.","journal-title":"Adv Immunol"},{"key":"1038_CR39","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1016\/j.chest.2019.05.009","volume":"156","author":"S Gupta","year":"2019","unstructured":"Gupta S, Pattanaik D, Krishnaswamy G. Common variable immune deficiency and associated complications. Chest. 2019;156:579\u201393.","journal-title":"Chest"},{"key":"1038_CR40","doi-asserted-by":"publisher","first-page":"2433","DOI":"10.3109\/10428194.2013.780655","volume":"54","author":"D Dierickx","year":"2013","unstructured":"Dierickx D, Tousseyn T, Sagaert X, Fieuws S, Wlodarska I, Morscio J, et al. Single-center analysis of biopsy-confirmed posttransplant lymphoproliferative disorder: incidence, clinicopathological characteristics and prognostic factors. Leuk Lymphoma. 2013;54:2433\u201340.","journal-title":"Leuk Lymphoma"},{"key":"1038_CR41","doi-asserted-by":"publisher","first-page":"425","DOI":"10.4132\/jptm.2018.04.16","volume":"52","author":"S Choi","year":"2018","unstructured":"Choi S, Go JH. Follicular T-cell lymphoma with concomitant Lennert lymphoma. J Pathol Transl Med. 2018;52:425\u20137.","journal-title":"J Pathol Transl Med"},{"key":"1038_CR42","first-page":"403","volume-title":"WHO classification of tumors of haematopoietic and lymphoid tissues: International Agency for Research on Cancer (IARC)","author":"ES Jaffe","year":"2017","unstructured":"Pileri SA, Weisenburger DD, Sng I, Nakamura S, M\u00fcller-Hermelink HK, Chan WC, Jaffe ES. Peripheral T-cell lymphoma, NOS. In: Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, J\u00fcrgen T, eds. WHO classification of tumors of haematopoietic and lymphoid tissues: International Agency for Research on Cancer (IARC), 2017. p. 403\u2013407."},{"key":"1038_CR43","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1097\/PAS.0000000000000694","volume":"40","author":"D Kurita","year":"2016","unstructured":"Kurita D, Miyoshi H, Yoshida N, Sasaki Y, Kato S, Niino D, et al. A clinicopathologic study of Lennert lymphoma and possible prognostic factors: the importance of follicular helper T-cell markers and the association with angioimmunoblastic T-cell lymphoma. Am J Surg Pathol. 2016;40:1249\u201360.","journal-title":"Am J Surg Pathol"},{"key":"1038_CR44","doi-asserted-by":"publisher","first-page":"248","DOI":"10.4103\/0377-4929.120379","volume":"56","author":"S Parimal","year":"2013","unstructured":"Parimal S, Pai R, Manipadam MT, Nair S. Lennert's lymphoma: clinicopathological profile of five cases. Indian J Pathol Microbiol. 2013;56:248\u201351.","journal-title":"Indian J Pathol Microbiol"},{"key":"1038_CR45","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1007\/s10875-018-0534-7","volume":"38","author":"J Leung","year":"2018","unstructured":"Leung J, Sullivan KE, Perelygina L, Icenogle JP, Fuleihan RL, Lanzieri TM. Prevalence of granulomas in patients with primary immunodeficiency disorders, United States: Data from National Health Care Claims and the US Immunodeficiency Network registry. J Clin Immunol. 2018;38:717\u201326.","journal-title":"J Clin Immunol"}],"container-title":["Diagnostic Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13000-020-01038-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13000-020-01038-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13000-020-01038-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,10]],"date-time":"2021-10-10T12:58:32Z","timestamp":1633870712000},"score":1,"resource":{"primary":{"URL":"https:\/\/diagnosticpathology.biomedcentral.com\/articles\/10.1186\/s13000-020-01038-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,9]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1038"],"URL":"https:\/\/doi.org\/10.1186\/s13000-020-01038-3","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-38626\/v2","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.3.rs-38626\/v1","asserted-by":"object"}]},"ISSN":["1746-1596"],"issn-type":[{"value":"1746-1596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,9]]},"assertion":[{"value":"1 July 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 September 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 October 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study complied with the Declaration of Helsinki and was approved by the Human and Animal Ethics Review Committees of Nippon Medical School, Japan (30\u2013-07-964).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patient for publication of this report and accompanying images.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"125"}}